Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 54

1.

Crystal structure of (NH4)2[Fe(II) 5(HPO3)6], a new open-framework phosphite.

Berrocal T, Mesa JL, Larrea E, Arrieta JM.

Acta Crystallogr Sect E Struct Rep Online. 2014 Oct 8;70(Pt 11):309-11. doi: 10.1107/S1600536814021783. eCollection 2014 Nov 1.

2.

Heterogeneous catalytic properties of unprecedented μ-O-[FeTCPP]2 dimers (H2TCPP = meso-tetra(4-carboxyphenyl)porphyrin): an unusual superhyperfine EPR structure.

Fidalgo-Marijuan A, Barandika G, Bazán B, Urtiaga MK, Larrea ES, Iglesias M, Lezama L, Arriortua MI.

Dalton Trans. 2015 Jan 7;44(1):213-22. doi: 10.1039/c4dt02250e.

PMID:
25371170
3.

A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system.

Aranda A, Bezunartea J, Casales E, Rodriguez-Madoz JR, Larrea E, Prieto J, Smerdou C.

Cell Mol Life Sci. 2014 Dec;71(23):4637-51. doi: 10.1007/s00018-014-1631-2. Epub 2014 May 3.

PMID:
24794511
4.

Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection.

Larrea E, Echeverria I, Riezu-Boj JI, Aldabe R, Guembe L, Sola I, Civeira MP, Sarobe P, Prieto J.

J Hepatol. 2014 Mar;60(3):482-9. doi: 10.1016/j.jhep.2013.10.016. Epub 2013 Oct 26.

PMID:
24418171
5.

Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes.

Lawrie CH, Larrea E, Larrinaga G, Goicoechea I, Arestin M, Fernandez-Mercado M, Hes O, Cáceres F, Manterola L, López JI.

J Pathol. 2014 Jan;232(1):32-42. doi: 10.1002/path.4296.

PMID:
24155122
6.

Usage of adenovirus expressing thymidine kinase mediated hepatocellular damage for enabling mouse liver repopulation with allogenic or xenogenic hepatocytes.

Moreno D, Balasiddaiah A, Lamas O, Duret C, Neri L, Guembe L, Galarraga M, Larrea E, Daujat-Chavanieu M, Muntane J, Maurel P, Riezu JI, Prieto J, Aldabe R.

PLoS One. 2013 Sep 24;8(9):e74948. doi: 10.1371/journal.pone.0074948. eCollection 2013.

7.

Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes.

Larrea E, Riezu-Boj JI, Aldabe R, Guembe L, Echeverria I, Balasiddaiah A, Gastaminza P, Civeira MP, Sarobe P, Prieto J.

Gut. 2014 Apr;63(4):665-73. doi: 10.1136/gutjnl-2012-304377. Epub 2013 Jun 20.

PMID:
23787026
8.

A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.

Sangro B, Gomez-Martin C, de la Mata M, Iñarrairaegui M, Garralda E, Barrera P, Riezu-Boj JI, Larrea E, Alfaro C, Sarobe P, Lasarte JJ, Pérez-Gracia JL, Melero I, Prieto J.

J Hepatol. 2013 Jul;59(1):81-8. doi: 10.1016/j.jhep.2013.02.022. Epub 2013 Mar 4.

PMID:
23466307
9.

Thermal response, catalytic activity, and color change of the first hybrid vanadate containing Bpe guest molecules.

Fernández de Luis R, Urtiaga MK, Mesa JL, Larrea ES, Iglesias M, Rojo T, Arriortua MI.

Inorg Chem. 2013 Mar 4;52(5):2615-26. doi: 10.1021/ic302662x. Epub 2013 Feb 14.

PMID:
23409737
10.

Validation of an antiviral assay method for quantifying IFN-α5 activity in macaque and human serum.

Arbillaga L, Murillo-Arbizu M, González I, Gil AG, Vettorazzi A, González-Peñas E, Larrea E, de Cerain AL.

Bioanalysis. 2013 Feb;5(3):289-305. doi: 10.4155/bio.12.313.

PMID:
23394696
11.

Amine templated open-framework vanadium(III) phosphites with catalytic properties.

Orive J, Larrea ES, Fernández de Luis R, Iglesias M, Mesa JL, Rojo T, Arriortua MI.

Dalton Trans. 2013 Apr 7;42(13):4500-12. doi: 10.1039/c2dt32286b.

PMID:
23340960
12.

Synthesis and comparative study of Co(pym)(VO3)2 and [Co(H2O)2(VO3)2]·2H2O.

Larrea ES, Mesa JL, Pizarro JL, Fernández de Luis R, Rodríguez Fernández J, Rojo T, Arriortua MI.

Dalton Trans. 2012 Dec 14;41(46):14170-9. doi: 10.1039/c2dt31531a. Epub 2012 Oct 4.

PMID:
23034532
13.

CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.

Hervas-Stubbs S, Mancheño U, Riezu-Boj JI, Larraga A, Ochoa MC, Alignani D, Alfaro C, Morales-Kastresana A, Gonzalez I, Larrea E, Pircher H, Le Bon A, Lopez-Picazo JM, Martín-Algarra S, Prieto J, Melero I.

J Immunol. 2012 Oct 1;189(7):3299-310. Epub 2012 Aug 27.

14.

N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

Van Damme P, Lasa M, Polevoda B, Gazquez C, Elosegui-Artola A, Kim DS, De Juan-Pardo E, Demeyer K, Hole K, Larrea E, Timmerman E, Prieto J, Arnesen T, Sherman F, Gevaert K, Aldabe R.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54. doi: 10.1073/pnas.1210303109. Epub 2012 Jul 18.

15.

Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B.

Otano I, Suarez L, Dotor J, Gonzalez-Aparicio M, Crettaz J, Olagüe C, Vales A, Riezu JI, Larrea E, Borras F, Benito A, Hernandez-Alcoceba R, Menne S, Prieto J, González-Aseguinolaza G.

Hepatology. 2012 Aug;56(2):474-83. doi: 10.1002/hep.25667. Epub 2012 Jul 2.

PMID:
22334260
16.

Flexible and dynamic thermal behavior of self-catenated [{Ni3(H2O)3(Bpa)4}(V6O18)]·8H2O constructed from 10-c heterometallic inorganic-organic clusters.

Fernández de Luis R, Mesa JL, Urtiaga MK, Larrea ES, Rojo T, Arriortua MI.

Inorg Chem. 2012 Feb 20;51(4):2130-9. doi: 10.1021/ic201951e. Epub 2012 Feb 3.

PMID:
22303905
17.

M(C6H16N3)2(VO3)4 as heterogeneous catalysts. Study of three new hybrid vanadates of cobalt(II), nickel(II) and copper(II) with 1-(2-aminoethyl)piperazonium.

Larrea ES, Mesa JL, Pizarro JL, Iglesias M, Rojo T, Arriortua MI.

Dalton Trans. 2011 Dec 21;40(47):12690-8. doi: 10.1039/c1dt10971e. Epub 2011 Oct 14.

PMID:
22002670
18.

Cardiotrophin-1 promotes a high survival rate in rabbits with lethal fulminant hepatitis of viral origin.

Tuñon MJ, San Miguel B, Crespo I, Riezu-Boj JI, Larrea E, Alvarez M, González I, Bustos M, González-Gallego J, Prieto J.

J Virol. 2011 Dec;85(24):13124-32. doi: 10.1128/JVI.05725-11. Epub 2011 Oct 5.

19.

Anchoring interferon alpha to apolipoprotein A-I reduces hematological toxicity while enhancing immunostimulatory properties.

Fioravanti J, González I, Medina-Echeverz J, Larrea E, Ardaiz N, González-Aseguinolaza G, Prieto J, Berraondo P.

Hepatology. 2011 Jun;53(6):1864-73. doi: 10.1002/hep.24306. Epub 2011 May 2.

PMID:
21425312
20.

Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.

Díaz-Valdés N, Manterola L, Belsúe V, Riezu-Boj JI, Larrea E, Echeverria I, Llópiz D, López-Sagaseta J, Lerat H, Pawlotsky JM, Prieto J, Lasarte JJ, Borrás-Cuesta F, Sarobe P.

Hepatology. 2011 Jan;53(1):23-31. doi: 10.1002/hep.23980. Epub 2010 Dec 13.

PMID:
21154952
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk